Literature DB >> 29215627

A Pharmacokinetic Rationale for Proactive Therapeutic Drug Monitoring of Anti-TNF Drugs.

Andrew R Reinink1,2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 29215627     DOI： 10.1038/ajg.2017.266

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN： 0002-9270            Impact factor:   10.864


× No keyword cloud information.
  5 in total

1.  A Real-life Population Pharmacokinetic Study Reveals Factors Associated with Clearance and Immunogenicity of Infliximab in Inflammatory Bowel Disease.

Authors:  Johannan F Brandse; Diane Mould; Oscar Smeekes; Yaël Ashruf; Sabine Kuin; Anne Strik; Gijs R van den Brink; Geert R DʼHaens
Journal:  Inflamm Bowel Dis       Date:  2017-04       Impact factor: 5.325

Review 2.  Therapeutic Drug Monitoring in IBD: Prospective Promise Unfulfilled.

Authors:  Shail M Govani; Akbar K Waljee
Journal:  Am J Gastroenterol       Date:  2017-03-21       Impact factor: 10.864

Review 3.  Therapeutic Drug Monitoring in IBD: The New Standard-of-Care for Anti-TNF Therapy.

Authors:  Konstantinos Papamichael; Adam S Cheifetz
Journal:  Am J Gastroenterol       Date:  2017-02-21       Impact factor: 10.864

4.  Pharmacokinetic properties of infliximab in children and adults with Crohn's disease: a retrospective analysis of data from 2 phase III clinical trials.

Authors:  Adedigbo A Fasanmade; Omoniyi J Adedokun; Marion Blank; Honghui Zhou; Hugh M Davis
Journal:  Clin Ther       Date:  2011-07-07       Impact factor: 3.393

5.  Proactive therapeutic concentration monitoring of infliximab may improve outcomes for patients with inflammatory bowel disease: results from a pilot observational study.

Authors:  Byron P Vaughn; Manuel Martinez-Vazquez; Vilas R Patwardhan; Alan C Moss; William J Sandborn; Adam S Cheifetz
Journal:  Inflamm Bowel Dis       Date:  2014-11       Impact factor: 5.325
  5 in total
  4 in total

1.  Response to Reinink.

Authors:  Konstantinos Papamichael; Adam S Cheifetz
Journal:  Am J Gastroenterol       Date:  2017-12       Impact factor: 10.864

2.  Dried blood samples can support monitoring of infliximab concentrations in patients with inflammatory bowel disease: A clinical validation.

Authors:  Sophie E Berends; Geert R A M D'Haens; Tiny Schaap; Annick de Vries; Theo Rispens; Karien Bloem; Ron A A Mathôt
Journal:  Br J Clin Pharmacol       Date:  2019-05-11       Impact factor: 4.335

Review 3.  The Evolving Role of Microsampling in Therapeutic Drug Monitoring of Monoclonal Antibodies in Inflammatory Diseases.

Authors:  Panagiotis-Dimitrios Mingas; Jurij Zdovc; Iztok Grabnar; Tomaž Vovk
Journal:  Molecules       Date:  2021-03-22       Impact factor: 4.411

Review 4.  Mass spectrometry-based metabolomics in health and medical science: a systematic review.

Authors:  Xi-Wu Zhang; Qiu-Han Li; Zuo-di Xu; Jin-Jin Dou
Journal:  RSC Adv       Date:  2020-01-17       Impact factor: 4.036
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.